Most boards I speak with assume their succession plans are watertight because they have mapped out every name, capability, and date on a clean timeline. Yet, almost none of them have factored in whether an incumbent can actually maintain the pace of their role right up to hand-off day.
That is the awkward operational blind spot: an executive’s track record, reputation, and sheer presence can easily mask gradual shifts in memory, processing speed, strategic judgement, or behaviour. By the time these quiet slips start hitting organisational performance, governance teams find themselves caught completely flat-footed.
I am not suggesting boards turn into medical clinics or start diagnosing executives in the boardroom. Rather, leadership continuity is fundamentally an operational health-risk challenge, and organisations need a far sharper framework to navigate it.
The risk hidden inside continuity
In my experience, boards treat succession almost exclusively as an HR mapping exercise. They build candidate matrices, file emergency cover policies, and review the executive pipeline. The Financial Reporting Council’s UK Corporate Governance Code guidance specifically draws lines between three things: short-term emergency cover for sudden departures, medium-term succession, and long-term strategic alignment of board skills. Crucially, the FRC explicitly cautions boards against building an excessive reliance on any single individual.
Real-world health changes rarely happen on a clean schedule. They creep in. According to NHS guidance, early warning signs can include memory loss, concentration problems, struggling with routine tasks, faltering over vocabulary, confusion, and subtle changes in mood. Crucially, mild cognitive impairment frequently emerges ahead of a dementia diagnosis, yet it does not automatically guarantee that dementia will develop.
From an operational standpoint, that nuance is everything. An executive can still hold a room, deliver a familiar keynote, and run a standard update without missing a beat. Put that same individual into high-stakes, fast-moving financial reconciliations, ambiguous multi-variable strategy sessions, or acute crisis decisions, and the seams begin to pull apart. Performance wavers. Peers predictably write it off as burnout, temporary strain, personality quirks, or simply bad delegation. By the time anyone names the real issue, proprietary knowledge has slipped away, investor confidence has taken a hit, and critical governance controls have been left riding on an executive who simply can no longer carry them.
The question succession committees should ask goes beyond simply identifying the next hire. We need to ask which concrete operating signals show our leadership setup is turning fragile or unsustainable.
Cognitive risk is not a diagnosis
Let me be clear about a major trap here: turning workforce health data into an informal surveillance apparatus. A low screening score, shifting absence patterns, or a quiet whisper from a line manager do not constitute a medical diagnosis. Boards must never use cognitive data points to sideline, label, or force out experienced leaders.
The proper lens is functional risk. The goal must be twofold: give senior leaders legitimate, structured support so they can thrive in their roles, while rigorously stress-testing the business to ensure no core function collapses without them. UK employment law supports this approach. Government guidance requires employers to implement reasonable adjustments where a disabled worker faces substantial disadvantage. In practice, that means adjusting working hours, providing targeted mentoring, reshaping information flows, or updating working equipment.
Boards carry an intertwined responsibility. They must rigorously defend an individual’s dignity, privacy, and employment protections, while simultaneously safeguarding the organisation from single-point-of-failure risk. Handled properly, a transition framework protects the executive's standing while steadily dispersing decision rights, customer relationships, and institutional knowledge to the broader bench.
Keep a strict operational boundary between cognitive risk data and medical files. While occupational health and HR legitimately hold clinical information, the board needs only functional risk intelligence: Are current adjustments delivering? Does the executive need a reduced remit? Are the contingency plans operational? Keep data access purposeful, tightly controlled, and governed strictly by standard UK GDPR and occupational health safeguards.
Where the succession plan fails
Standard executive assessments are heavily biased toward visible outputs. Solid revenue growth, commanding boardroom presence, deep industry networks, and decades of standing frequently blind boards to early friction in executive functioning. Concentrated authority simply amplifies that exposure.
Consider what happens when a chief executive retains total strategic veto but struggles to process dense late-stage briefings. Decision latency spikes, and they retreat into a trusted inner circle. Consider a finance director who still presents cleanly to investors, but quietly fumbles intricate reconciliations while internal sign-offs rely increasingly on informal shortcuts. Or an operations leader whose technical judgements were never codified, leaving the firm exposed because institutional wisdom sits entirely inside their head.
Cognitive risk is an operational resilience issue, not a private medical sideshow. Boards should test their exposure directly against these operational checks:
- Which approvals, executive judgements, and critical relationships are locked into one desk?
- Can a deputy take over core operational mandates tomorrow morning without derailing operations?
- Has the nominated successor actually executed high-stakes authority, or have they simply sat in the room shadowing it?
- Which internal financial controls buckle if the incumbent needs extended sick leave or a reduced remit?
- Is operational delegation a baked-in daily reality, or a frantic scramble triggered only during a crisis?
The FRC guidance gives boards an actionable baseline: succession planning must be strategic, forward-looking, and documented in writing. Factoring in cognitive risk adds an essential operational check: transition plans must evaluate the operational resilience of the seat itself, rather than resting on assumptions about an executive's age, stamina, or future health.
Implications across the enterprise
Within People and HR functions, this reality sits squarely across inclusion, occupational health, and workforce planning. CIPD data shows that over half of UK employees live with a long-term health condition by age 60. While that statistic does not equal cognitive decline, it highlights that managing health-related transitions is routine operational territory for an ageing workforce. HR needs to equip line managers to spot functional shifts without turning into amateur clinicians. The right path is an open, supportive dialogue, an occupational health referral where necessary, and an honest review of workplace adjustments focused on practical outcomes rather than diagnostic tags.
For the Finance function, key-person vulnerability undermines internal control. When one person holds the keys to treasury sign-offs, strategic forecasting, capital allocation, or board-level challenges, governance falters. Finance teams must identify precisely where informal workarounds have replaced clear controls, and where an executive’s unwritten memory has quietly substituted for documented procedure.
Risk leaders must incorporate cognitive exposure directly into enterprise risk registers and operational stress scenarios. It belongs alongside acute illness, executive burnout, sudden departures, and macro shocks. HSE’s Management Standards framework is especially relevant here: its six core arenas—demands, control, support, relationships, role, and change—show how unmanaged workplace pressure directly accelerates cognitive fatigue, impairs decision-making, and creates execution errors.
For insurance partners, this directly affects Directors’ and Officers’ liability, key-person policies, business interruption covers, and private healthcare exposure. Underwriters do not expect boards to predict medical events; they expect companies to demonstrate defensible governance, structured controls, and verified leadership continuity.
Five actions for senior leaders
First, build health-related operational resilience into every succession review without resorting to medical profiling. Map out where critical sign-offs cluster, and evaluate how the business operates if a key leader shifts to part-time working, steps back, or takes sudden leave.
Secondly, establish a documented, confidential escalation protocol. Ensure department heads know precisely how to report sustained operational performance dips, who owns the triage, when occupational health steps in, and how candidate privacy stays locked down.
Thirdly, stress-test your succession documents against a gradual capacity drop, instead of planning solely for an abrupt exit or sudden resignation. Clarify how work gets delivered if an incumbent leader remains in the seat but can no longer sustain heavy international travel, relentless round-the-clock decision cycles, or multiple high-intensity stakeholder negotiations.
Fourthly, institutionalise knowledge transfer and cross-skilling immediately. Give designated deputies real authority to front critical client accounts, sign off budgets, and present strategic items to the board while the incumbent is performing at their peak. That builds actual operational capability and avoids the toxic assumption that delegation equals a vote of no confidence.
Finally, route these discussions through proper governance channels. Boards require objective data on functional dependency, control risks, work adjustments, and replacement readiness; they have no business reviewing an individual’s confidential medical notes. Maintaining that line safeguards the leader and the firm at the same time.
The leadership issue boards cannot defer
Using early cognitive indicators is not about grading a leader's worthiness. It is about proving your organisation has the governance maturity to support individuals properly without leaving enterprise decisions hanging on a single thread.
The most resilient transition models do not wait for an operational shock, a medical verdict, or a sudden crisis to force their hand. They institutionalise handovers, stress-test deputies under real pressure, protect personal dignity, and measure operational continuity long before they are forced to.
Look at your current leadership succession plan and ask yourself: does it rely on your leaders maintaining flawless health, or is your organisation actually structured to absorb cognitive reality? If it is the former, your succession strategy is merely a list of names. Rewrite it today.